6533b7d1fe1ef96bd125c382
RESEARCH PRODUCT
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.
Marie A. NeuArthur WingerterSebastian AttigEva-m. FehrAlexander HohbergerBettina KronFrancesca AltKhalifa El MalkiAlexandra RussoNadine LehmannJörg FaberJeannette FischerLea RothClaudia ParetThomas Kindlersubject
0301 basic medicineMaleCancer Researchmedicine.medical_treatmentT-LymphocytesEpitopes T-LymphocyteT-Cell Antigen Receptor SpecificityImmunotherapy AdoptiveEpitopeCohort StudiesExon0302 clinical medicineimmune system diseasesImmunology and AllergyMedicineProtein IsoformsChildAged 80 and overbiologyCD19CART-19B-ALLMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomaepitope-lossmedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisChild PreschoolComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFemaleClone (B-cell biology)Gene isoformAdultAdolescentRecombinant Fusion ProteinsImmunologyAntigens CD19Receptors Antigen T-CellCancer VaccinesCD1903 medical and health sciencesYoung AdultAntigenHumansAgedPharmacologybusiness.industryInfant NewbornisoformsInfantImmunotherapy030104 developmental biologyImmunologybiology.proteinClinical StudyTumor EscapeBone marrowbusinessdescription
Supplemental Digital Content is available in the text.
year | journal | country | edition | language |
---|---|---|---|---|
2017-04-26 | Journal of immunotherapy (Hagerstown, Md. : 1997) |